Evidence map›Paper›PMID 25833686›Full record

ArticleJournal of lipid research2015

Human monocyte-derived dendritic cells turn into foamy dendritic cells with IL-17A.

Giulia Salvatore, Nathalie Bernoud-Hubac, Nathalie Bissay, Cyrille Debard, Patricia Daira, Emmanuelle Meugnier, Fabienne Proamer, Daniel Hanau, Hubert Vidal, Maurizio Aricò and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Lipid Metabolism in Tumor-Associated Natural Killer Cells.Advances in experimental medicine and biology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Giulia SalvatoreCNRS, UMR5239, Laboratoire de Biologie Moléculaire de la Cellule, 69007 Lyon, France Ecole Normale Supérieure de Lyon, 69007 Lyon, France Université de Lyon, 69003 Lyon, France Université de Lyon 1, 69622 Villeurbanne, France Université de Florence, 50134 Florence, Italy.
Nathalie Bernoud-HubacINSERM, U 1060 (CarMeN), INRA U1235, Institut Multidisciplinaire de Biochimie des Lipides, Institut National des Sciences Appliqués, 69621 Villeurbanne, France.
Nathalie BissayCNRS, UMR5239, Laboratoire de Biologie Moléculaire de la Cellule, 69007 Lyon, France Ecole Normale Supérieure de Lyon, 69007 Lyon, France Université de Lyon, 69003 Lyon, France Université de Lyon 1, 69622 Villeurbanne, France.
Cyrille DebardINSERM, U 1060 (CarMeN), INRA U1235, Institut Multidisciplinaire de Biochimie des Lipides, Institut National des Sciences Appliqués, 69621 Villeurbanne, France.
Patricia DairaFunctional Lipidomics Platform, Institut Multidisciplinaire de Biochimie des Lipides/Carnot Lisa, INSA-Lyon, 69622 Villeurbanne, France.
Emmanuelle MeugnierINSERM, U 1060 (CarMeN), INRA U1235, Institut Multidisciplinaire de Biochimie des Lipides, Institut National des Sciences Appliqués, 69621 Villeurbanne, France.
Fabienne ProamerUnité Mixte de Recherche Santé UMR S949, Institut National de la Santé et de la Recherche Médicale, 67000 Strasbourg, France Université de Strasbourg, 67400 Strasbourg, France Histocompatibility Laboratory, Etablissement Français du Sang-Alsace, 67000 Strasbourg, France.
Daniel HanauUnité Mixte de Recherche Santé UMR S949, Institut National de la Santé et de la Recherche Médicale, 67000 Strasbourg, France Université de Strasbourg, 67400 Strasbourg, France Histocompatibility Laboratory, Etablissement Français du Sang-Alsace, 67000 Strasbourg, France.
Hubert VidalINSERM, U 1060 (CarMeN), INRA U1235, Institut Multidisciplinaire de Biochimie des Lipides, Institut National des Sciences Appliqués, 69621 Villeurbanne, France.
Maurizio AricòIstituto Toscano Tumori (I.T.T), 50139 Florence, Italy Azienda Sanitaria Provinciale 7, 97100 Ragusa, Italy.
Christine DelpratCNRS, UMR5239, Laboratoire de Biologie Moléculaire de la Cellule, 69007 Lyon, France Ecole Normale Supérieure de Lyon, 69007 Lyon, France Université de Lyon, 69003 Lyon, France Université de Lyon 1, 69622 Villeurbanne, France Institut Universitaire de France, 75005 Paris, France.
Karène MahtoukCNRS, UMR5239, Laboratoire de Biologie Moléculaire de la Cellule, 69007 Lyon, France Ecole Normale Supérieure de Lyon, 69007 Lyon, France Université de Lyon, 69003 Lyon, France Université de Lyon 1, 69622 Villeurbanne, France.
Inserm · FRLaboratoire de Biologie et Modélisation de la Cellule · FRUniversité Claude Bernard Lyon 1 · FRAgenzia Regionale Sanitaria della Puglia · ITÉtablissement Français du Sang · FRInstitut National des Sciences Appliquées de Lyon · FRLaboratoire CarMeN · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin 17A (IL-17A) is a proinflammatory cytokine involved in the pathogenesis of chronic inflammatory diseases. In the field of immunometabolism, we have studied the impact of IL-17A on the lipid metabolism of human in vitro-generated monocyte-derived dendritic cells (DCs). Microarrays and lipidomic analysis revealed an intense remodeling of lipid metabolism induced by IL-17A in DCs. IL-17A increased 2-12 times the amounts of phospholipids, cholesterol, triglycerides, and cholesteryl esters in DCs. Palmitic (16:0), stearic (18:0), and oleic (18:ln-9c) acid were the main fatty acid chains present in DCs. They were strongly increased in response to IL-17A while their relative proportion remained unchanged. Capture of extracellular lipids was the major mechanism of lipid droplet accumulation, visualized by electron microscopy and Oil Red O staining. Besides this foamy phenotype, IL-17A induced a mixed macrophage-DC phenotype and expression of the nuclear receptor NR1H3/liver X receptor-α, previously identified in the context of atherosclerosis as the master regulator of cholesterol homeostasis in macrophages. These IL-17A-treated DCs were as competent as untreated DCs to stimulate allogeneic naive T-cell proliferation. Following this first characterization of lipid-rich DCs, we propose to call these IL-17A-dependent cells "foamy DCs" and discuss the possible existence of foamy DCs in atherosclerosis, a metabolic and inflammatory disorder involving IL-17A.

Indexed as

AtherosclerosisCell DifferentiationCell ProliferationDendritic CellsFatty AcidsFoam CellsGene Expression RegulationHumansInterleukin-17Lipid DropletsLipid MetabolismLiver X ReceptorsMacrophagesMonocytesOrphan Nuclear ReceptorsT-LymphocytesFatty AcidsIL17A protein, humanInterleukin-17Liver X ReceptorsNR1H3 protein, humanOrphan Nuclear Receptorsimmunologyimmunometabolisminflammationinterleukin 17Alipidlipidomicsmicroarraysmonocytes

Identifiers

PMID25833686
PMCPMC4442869
OpenAlexW2034541702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.